PLMA_1170x120_10-8-21

Ertapenem

Dr. Reddy’s announces the launch of Ertapenem for Injection in the U.S. market

Dr. Reddy’s announces the launch of Ertapenem for Injection in the U.S. market

HYDERBAD, India and PRINCETON, N.J. —  Dr. Reddy’s Laboratoriesannounced the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of INVANZ (ertapenem for injection) for injection, 1 g/vial approved by the U.S. Food and Drug Administration (USFDA). “We are pleased to bring this important product to market at this time,” says Marc